L1CAM malfunction in the nervous system and human carcinomas

被引:0
作者
Michael K. E. Schäfer
Peter Altevogt
机构
[1] University of Freiburg,Center for Neurosciences, Institute of Anatomy and Cell Biology
[2] German Cancer Research Center,D015
来源
Cellular and Molecular Life Sciences | 2010年 / 67卷
关键词
Cell adhesion molecule; Neurological disorders; L1 syndrome; Cancer; Cell migration;
D O I
暂无
中图分类号
学科分类号
摘要
Research over the last 25 years on the cell adhesion molecule L1 has revealed its pivotal role in nervous system function. Mutations of the human L1CAM gene have been shown to cause neurodevelopmental disorders such as X-linked hydrocephalus, spastic paraplegia and mental retardation. Impaired L1 function has been also implicated in the aetiology of fetal alcohol spectrum disorders, defective enteric nervous system development and malformations of the renal system. Importantly, aberrant expression of L1 has emerged as a critical factor in the development of human carcinomas, where it enhances cell proliferation, motility and chemoresistance. This discovery promoted collaborative work between tumour biologists and neurobiologists, which has led to a substantial expansion of the basic knowledge about L1 function and regulation. Here we provide an overview of the pathological conditions caused by L1 malfunction. We further discuss how the available data on gene regulation, molecular interactions and posttranslational processing of L1 may contribute to a better understanding of associated neurological and cancerous diseases.
引用
收藏
页码:2425 / 2437
页数:12
相关论文
共 50 条
  • [31] Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
    Tangen, Ingvild L.
    Kopperud, Reidun K.
    Visser, Nicole C. M.
    Staff, Anne C.
    Tingulstad, Solveig
    Marcickiewicz, Janusz
    Amant, Frederc
    Bjorge, Line
    Pijnenborg, Johanna M. A.
    Salvesen, Helga B.
    Werner, Henrica M. J.
    Trovik, Jone
    Krakstad, Camilla
    BRITISH JOURNAL OF CANCER, 2017, 117 (06) : 840 - 847
  • [32] L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma
    Romani, Chiara
    Capoferri, Davide
    Reijnen, Casper
    Lonardi, Silvia
    Ravaggi, Antonella
    Ratti, Martina
    Bugatti, Mattia
    Zanotti, Laura
    Tognon, Germana
    Sartori, Enrico
    Odicino, Franco
    Calza, Stefano
    Pijnenborg, Johanna M. A.
    Bignotti, Eliana
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (04) : 637 - 648
  • [33] Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas
    Huszar, Monica
    Pfeifer, Marco
    Schirmer, Uwe
    Kiefel, Helena
    Konecny, Gottfried E.
    Ben-Arie, Alon
    Edler, Lutz
    Muench, Maria
    Mueller-Holzner, Elisabeth
    Jerabek-Klestil, Susanne
    Abdel-Azim, Samira
    Marth, Christian
    Zeimet, Alain G.
    Altevogt, Peter
    Fogel, Mina
    JOURNAL OF PATHOLOGY, 2010, 220 (05) : 551 - 561
  • [34] Novel L1CAM Splice Site Mutation in a Young Male With L1 Syndrome
    Rehnberg, Malin
    Jonasson, Jon
    Gunnarsson, Cecilia
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (02) : 439 - 441
  • [35] L1cam curbs the differentiation of adult-born hippocampal neurons
    Gronska-Peski, Marta
    Schachner, Melitta
    Hebert, Jean M.
    STEM CELL RESEARCH, 2020, 48
  • [36] Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma
    Song, In Ho
    Jeong, Mun Sik
    Hong, Hyo Jeong
    Shin, Jong Il
    Park, Yong Serk
    Woo, Sang-Keun
    Moon, Byung Seok
    Kim, Kwang Il
    Lee, Yong Jin
    Kang, Joo Hyun
    Lee, Tae Sup
    CLINICAL CANCER RESEARCH, 2019, 25 (20) : 6148 - 6159
  • [37] Neuropsin promotes hippocampal synaptogenesis by regulating the expression and cleavage of L1CAM
    Barman, Bhabotosh
    Thakur, Mahendra Kumar
    JOURNAL OF CELL SCIENCE, 2024, 137 (03)
  • [38] Utility of Mesothelin, L1CAM and Afamin as Biomarkers in Primary Ovarian Cancer
    Aktas, Bahriye
    Kasimir-Bauer, Sabine
    Wimberger, Pauline
    Kimmig, Rainer
    Heubner, Martin
    ANTICANCER RESEARCH, 2013, 33 (01) : 329 - 336
  • [39] L1CAM: amending the "low-risk" category in endometrial carcinoma
    Kommoss, Felix
    Kommoss, Friedrich
    Grevenkamp, Friederike
    Bunz, Anne-Kathrin
    Taran, Florin-Andrei
    Fend, Falko
    Brucker, Sara Y.
    Wallwiener, Diethelm
    Schoenfisch, Birgitt
    Greif, Karen
    Lax, Sigurd
    Staebler, Annette
    Kommoss, Stefan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (02) : 255 - 262
  • [40] L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion
    de Freitas, Daniela
    Aguiar, Fernando Nalesso
    Anton, Cristina
    Bacchi, Carlos Eduardo
    Carvalho, Jesus Paula
    Carvalho, Filomena Marino
    PLOS ONE, 2018, 13 (12):